Concepts (56)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Helminth | 2 | 2012 | 6 | 0.800 |
Why?
|
| Caenorhabditis | 2 | 2012 | 7 | 0.480 |
Why?
|
| Caenorhabditis elegans | 2 | 2012 | 223 | 0.440 |
Why?
|
| RNA, Small Untranslated | 1 | 2012 | 14 | 0.420 |
Why?
|
| Multigene Family | 1 | 2012 | 202 | 0.400 |
Why?
|
| Baclofen | 3 | 2016 | 15 | 0.380 |
Why?
|
| RNA, Small Nucleolar | 1 | 2009 | 5 | 0.370 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2021 | 36 | 0.350 |
Why?
|
| GABA-B Receptor Agonists | 2 | 2016 | 5 | 0.270 |
Why?
|
| Fragile X Syndrome | 2 | 2017 | 15 | 0.270 |
Why?
|
| Rare Diseases | 1 | 2021 | 59 | 0.200 |
Why?
|
| Genome, Helminth | 2 | 2012 | 5 | 0.200 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 1169 | 0.170 |
Why?
|
| Neurotransmitter Agents | 1 | 2017 | 106 | 0.150 |
Why?
|
| Autism Spectrum Disorder | 1 | 2016 | 76 | 0.130 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2014 | 39 | 0.120 |
Why?
|
| Behavior | 1 | 2012 | 85 | 0.110 |
Why?
|
| Nervous System | 1 | 2012 | 86 | 0.100 |
Why?
|
| Operon | 1 | 2009 | 48 | 0.090 |
Why?
|
| RNA Splice Sites | 1 | 2009 | 53 | 0.090 |
Why?
|
| Introns | 1 | 2009 | 289 | 0.080 |
Why?
|
| Bayes Theorem | 1 | 2009 | 361 | 0.080 |
Why?
|
| Species Specificity | 1 | 2009 | 678 | 0.080 |
Why?
|
| Computational Biology | 1 | 2009 | 528 | 0.070 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 813 | 0.070 |
Why?
|
| DiGeorge Syndrome | 1 | 2004 | 14 | 0.060 |
Why?
|
| Phylogeny | 1 | 2009 | 1137 | 0.060 |
Why?
|
| Animals | 3 | 2017 | 26582 | 0.060 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2004 | 68 | 0.060 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 129 | 0.060 |
Why?
|
| Algorithms | 1 | 2009 | 1830 | 0.050 |
Why?
|
| Child | 4 | 2016 | 6927 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2004 | 819 | 0.050 |
Why?
|
| Cognition | 1 | 2004 | 570 | 0.040 |
Why?
|
| Research Design | 1 | 2021 | 594 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 104 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2016 | 7993 | 0.040 |
Why?
|
| Adolescent | 3 | 2016 | 8981 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2012 | 502 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 399 | 0.030 |
Why?
|
| Akathisia, Drug-Induced | 1 | 2014 | 4 | 0.030 |
Why?
|
| Irritable Mood | 1 | 2014 | 10 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 865 | 0.030 |
Why?
|
| Young Adult | 2 | 2016 | 5976 | 0.030 |
Why?
|
| Humans | 6 | 2021 | 86643 | 0.030 |
Why?
|
| Male | 4 | 2016 | 40965 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2016 | 3612 | 0.020 |
Why?
|
| Female | 4 | 2016 | 44532 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 2705 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2004 | 43 | 0.020 |
Why?
|
| Valine | 1 | 2004 | 69 | 0.020 |
Why?
|
| Methionine | 1 | 2004 | 66 | 0.020 |
Why?
|
| Alleles | 1 | 2004 | 1128 | 0.010 |
Why?
|
| Genotype | 1 | 2004 | 1851 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 2271 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 25648 | 0.010 |
Why?
|